Decoding the complexity of Alzheimer's disease

Alzheimer's disease affects more than 6 million people in the United States, and there are very few FDA-approved treatments that can slow the progression of the disease.

Diseases, Conditions, Syndromes

Self-sampling proves effective in diagnosing asymptomatic mpox

An article published in Nature Communications on the pilot study carried out in Catalonia to evaluate the self-collection of biological samples reveals the high acceptability of the proposal and the key role of diagnosis ...

page 1 from 3